Published

29 Apr 25

Updated

15 Jun 26

Views

106

Not Invested

Fair Value

US$3.5

Share price15 Jun

US$0.3191.1% undervalued

Loading

1Y-89.24%

7D-6.45%

Lifeline Programs And Digital Banking Will Unlock Future Value

AN

AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published

29 Apr 25

Updated

15 Jun 26

Views

106

Not Invested

Shared on 15 Jun 26

Fair value Decreased 30%

SURG: Going Concern Risk Will Contrast With Anticipated Profit Margin Support

SurgePays faces new pressure from Nasdaq compliance warnings and an audit note that questions whether the business can keep operating as-is. At the same time, it rolls out new tools for retailers and a mobile wallet partnership that could open fresh ways to earn from its store network.

6 views

Shared on 01 Jun 26

SURG: Higher Profit Margin Outlook Will Support Upside Despite Listing Risks

SurgePays faces a new Nasdaq warning that could put its listing at risk, alongside auditor doubts and late regulatory filings that raise fresh questions about stability. At the same time, new product partnerships and a more optimistic view of future profitability shape how investors may think about what the business could deliver next.

9 views

Shared on 03 May 26

SURG: Higher Future P/E Will Support Upside Despite Margin And Listing Risks

Analysts have trimmed their price target on SurgePays by $4.75, citing updated assumptions on profit margins and future P/E levels, even as fair value, discount rate, and revenue growth inputs remain broadly consistent. Analyst Commentary Bullish Takeaways Bullish analysts view the updated price target trim as mainly reflecting refreshed assumptions on profit margins and P/E levels, rather than a shift in views on the company’s core business or revenue potential.

7 views

Shared on 17 Apr 26

Fair value Decreased 44%

SURG: Premium Future P/E Will Support Upside Despite Lower Margin Assumptions

Analysts lowered their price target on SurgePays by $4.75 to $5.00, reflecting updated assumptions for slower revenue growth, a lower profit margin of 3.16% and a higher future P/E of about 43.53x. Analyst Commentary Bullish Takeaways Bullish analysts still see upside potential relative to the revised US$5.00 price target, given the higher assumed P/E of about 43.53x.

3 views

Fair Value vs Share Price

US$3.5

vs US$0.3191.1% undervalued

13.4%

Revenue growth

11.6%

Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on SurgePays

Fair value estimate changes
Narrative and analyst updates
Key company announcements

Company analysis

Moderate risk and fair value.

Market capUS$7.9m

PB-0.3x

Estimated Growth15.0%

Dividend YieldN/A

CEO & management

Kevin Cox

CEO

0.7yrs

CEO Tenure

Operates as a financial technology and telecom company in the United States.